{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:17:07Z","timestamp":1759540627057,"version":"3.37.3"},"reference-count":23,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Children's Hospital of Eastern Ontario Research Institute Capacity Building Program"},{"name":"Children's Hospital of Eastern Ontario Departments of Pediatrics and Surgery"},{"name":"Children's Hospital of Eastern Ontario Department of Surgery"},{"name":"University of Ottawa Research Chair Programme"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1210\/js.2018-00268","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T09:06:32Z","timestamp":1552295192000},"page":"857-864","source":"Crossref","is-referenced-by-count":5,"title":["The Bone Phenotype and Pain Response to Pamidronate in Tyrosine Kinase Inhibitor\u2013Treated Chronic Myelogenous Leukemia"],"prefix":"10.1210","volume":"3","author":[{"given":"Declan C T","family":"Lavoie","sequence":"first","affiliation":[{"name":"Pediatric Bone Health Clinical Research Program, Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Eve","family":"Robinson","sequence":"additional","affiliation":[{"name":"Pediatric Bone Health Clinical Research Program, Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Pediatrics, Division of Endocrinology, Children\u2019s Hospital of Eastern Ontario, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Children\u2019s Hospital of Eastern Ontario, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Pag\u00e9","sequence":"additional","affiliation":[{"name":"Pediatric Bone Health Clinical Research Program, Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor N","family":"Konji","sequence":"additional","affiliation":[{"name":"Pediatric Bone Health Clinical Research Program, Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[{"name":"Shriners Hospital for Children, Montr\u00e9al, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-9185","authenticated-orcid":false,"given":"Leanne M","family":"Ward","sequence":"additional","affiliation":[{"name":"Pediatric Bone Health Clinical Research Program, Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Pediatrics, Division of Endocrinology, Children\u2019s Hospital of Eastern Ontario, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"issue":"1","key":"2019041310492621100_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/bjh.12977","article-title":"Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years","volume":"167","author":"de la Fuente","year":"2014","journal-title":"Br J Haematol"},{"issue":"18","key":"2019041310492621100_bib2","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1517\/14656566.8.18.3257","article-title":"Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure","volume":"8","author":"Hochhaus","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"2019041310492621100_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2016.08.011","article-title":"Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America","volume":"67","author":"Karalexi","year":"2016","journal-title":"Eur J Cancer"},{"issue":"1","key":"2019041310492621100_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pcl.2014.09.008","article-title":"Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions","volume":"62","author":"Hijiya","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"2019041310492621100_bib5","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.bbmt.2010.09.003","article-title":"Controversies in the treatment of CML in children and adolescents: TKIs versus BMT","volume":"17","author":"Suttorp","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019041310492621100_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2008.09.072","article-title":"Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn\u2019s disease","volume":"136","author":"Dubner","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"2019041310492621100_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","article-title":"Normative data for iliac bone histomorphometry in growing children","volume":"26","author":"Glorieux","year":"2000","journal-title":"Bone"},{"volume-title":"Dietary Reference Intakes for Calcium and Vitamin D","year":"2011","author":"Institute of Medicine","key":"2019041310492621100_bib8"},{"issue":"2","key":"2019041310492621100_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jc.2006-1706","article-title":"Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years","volume":"92","author":"Rauchenzauner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041310492621100_bib10","volume-title":"Radiographic Atlas of Skeletal Development of the Hand and Wrist","author":"Greulich","year":"1959","edition":"2nd ed"},{"issue":"5","key":"2019041310492621100_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/pbc.24313","article-title":"Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia","volume":"60","author":"Leblicq","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019041310492621100_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1210\/jc.2012-2426","article-title":"Prospective histomorphometric and DXA evaluation of bone remodeling in imatinib-treated CML patients: evidence for site-specific skeletal effects","volume":"98","author":"Vandyke","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041310492621100_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/leu.2011.217","article-title":"Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR-ABL inhibitors as first-line therapy","volume":"26","author":"Shami","year":"2012","journal-title":"Leukemia"},{"issue":"22","key":"2019041310492621100_bib14","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2007.12.3430","article-title":"Bone density in breast cancer: when to intervene","volume":"25","author":"Gralow","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019041310492621100_bib15","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1359\/jbmr.1997.12.10.1746","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone","volume":"12","author":"Chapurlat","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2019041310492621100_bib16","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1007\/s00198-016-3723-3","article-title":"Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment","volume":"27","author":"Trejo","year":"2016","journal-title":"Osteoporos Int"},{"issue":"5","key":"2019041310492621100_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/rheumatology\/39.5.567","article-title":"Use of pamidronate for acute pain relief following osteoporotic vertebral fractures","volume":"39","author":"Abdulla","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"2019041310492621100_bib18"},{"issue":"3","key":"2019041310492621100_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/ped.13136","article-title":"Adverse effects of imatinib in children with chronic myelogenous leukemia","volume":"59","author":"Choeyprasert","year":"2017","journal-title":"Pediatr Int (Roma)"},{"issue":"8","key":"2019041310492621100_bib20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/pbc.26028","article-title":"Recognizing endocrinopathies associated with tyrosine kinase inhibitor therapy in children with chronic myelogenous leukemia","volume":"63","author":"Samis","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2019041310492621100_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-0033-1343483","article-title":"TK inhibitor treatment disrupts growth hormone axis: clinical observations in children with CML and experimental data from a juvenile animal model","volume":"225","author":"Ulmer","year":"2013","journal-title":"Klin Padiatr"},{"issue":"11","key":"2019041310492621100_bib22","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society","volume":"85","author":"GH Research Society","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041310492621100_bib23","doi-asserted-by":"crossref","first-page":"e0131192","DOI":"10.1371\/journal.pone.0131192","article-title":"Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats","volume":"10","author":"Tauer","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/3\/5\/857\/28398275\/js.2018-00268.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T10:49:44Z","timestamp":1555152584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/3\/5\/857\/5371328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,3,11]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2018-00268","relation":{},"ISSN":["2472-1972"],"issn-type":[{"type":"electronic","value":"2472-1972"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,3,11]]}}}